Literature DB >> 6234507

Cost-benefit analysis of neonatal intensive care for infants weighing less than 1,000 grams at birth.

D J Walker, A Feldman, B R Vohr, W Oh.   

Abstract

Cost-benefit analysis was performed on the care of 247 infants weighing between 500 and 999 g at birth, admitted to Women and Infants Hospital of Rhode Island between January 1977 and December 1981. The neonatal mortality was 68%. Eighty-seven percent of the survivors were evaluated neurodevelopmentally for 1 to 5 years: 74% were normal or minimally impaired, 10% were moderately impaired, and 16% were severely handicapped. Using these data in conjunction with cost information obtained from the hospital and therapeutic care facilities for handicapped children, total lifetime costs for the care of these infants were estimated. In 1982 dollars, present values of costs ranged from $362,992 per survivor for those weighing between 600 and 699 g to $40,647 per survivor for those weighing between 900 and 999 g, resulting in an inverse correlation between cost per survivor and birth weight (P less than .001). We estimated present values of expected lifetime earnings per survivor, with a range of zero earnings for infants between 500 and 699 g, to $77,084 for those with birth weight of 900 to 999 g. It is concluded that from the standpoint of cost-benefit analysis as was used for this study population, neonatal intensive care may not be justifiable for infants weighing less than 900 g at birth.

Entities:  

Mesh:

Year:  1984        PMID: 6234507

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  The long-term prognosis of pre-term infants: conceptual, methodological, and ethical issues.

Authors:  Linda S Siegel
Journal:  Hum Nat       Date:  1994

2.  Cost effectiveness of beractant in the prevention of respiratory distress syndrome.

Authors:  R F Soll; J Jacobs; S Pashko; R Thomas
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

3.  Cost implications of different approaches to the prevention of respiratory distress syndrome.

Authors:  M Mugford; J Piercy; I Chalmers
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

4.  Predicting the future for newborns requiring intensive care.

Authors:  L A Papile
Journal:  Hum Nat       Date:  1994-03

Review 5.  The economics and cost-effectiveness of critical care medicine.

Authors:  D B Chalfin; I L Cohen; J Lambrinos
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

Review 6.  Neonatal intensive care and cost effectiveness.

Authors:  G W Chance
Journal:  CMAJ       Date:  1988-11-15       Impact factor: 8.262

7.  Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome.

Authors:  H M Bryson; R Whittington
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

8.  The cost of neonatal care: reviewing the evidence.

Authors:  M Mugford
Journal:  Soz Praventivmed       Date:  1995

9.  Low birth weight and preterm birth: the emerging importance of prevention.

Authors:  E Siegel
Journal:  Soz Praventivmed       Date:  1985

10.  Cost of neonatal intensive care for extremely preterm infants in Canada.

Authors:  Asaph Rolnitsky; Sharon L Unger; David R Urbach; Chaim M Bell
Journal:  Transl Pediatr       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.